Spotlight on Mobocertinib (TAK-788) in NSCLC with EGFR Exon 20 Insertion Mutations

Overview of attention for article published in Lung Cancer: Targets and Therapy, July 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#12 of 128)
High Attention Score compared to outputs of the same age (82nd percentile)

Mentioned by

blogs: 1 blog
twitter: 1 X user

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 27 Mendeley

Summary Blogs X Wikipedia Dimensions citations

So far, Altmetric has seen 1 blog post.

Mobocertinib

New Drug Approvals, 23 Sep 2021

Mobocertinib 1847461-43-1 MF C32H39N7O4MW 585.70 propan-2-yl 2-[4-[2-(dimethylamino)ethyl-methylamino]-2-methoxy-5-(prop…